Dissecting cellulitis of the scalp is a chronic inflammatory condition in which deep, painful nodules and abscesses form on the scalp, often connecting beneath the skin through tunnels called sinuses. Left untreated, it destroys hair follicles and causes permanent scarring hair loss. Despite its name, the disease is not a bacterial infection in the traditional sense; it begins with clogged hair follicles and an exaggerated inflammatory response, though bacteria can pile on and make things worse. The condition is uncommon enough that many people go months or years before getting a correct diagnosis, and the treatment landscape has shifted considerably in recent years with the arrival of biologic drugs.
Who Gets It
Dissecting cellulitis overwhelmingly affects young men of African descent. A study of 71 patients found a male-to-female ratio of roughly 10 to 1, with a mean age of about 22 years and more than three-quarters of patients younger than 32.1Dermatologic Therapy. Demographic and Histopathological Evaluation in 71 Patients Diagnosed with Dissecting Cellulitis of the Scalp Broader clinical literature confirms that the condition is predominantly found in men of Afro-Caribbean descent during early adulthood or middle age, though women and white individuals are occasionally affected.2PubMed Central. Dissecting Cellulitis of the Scalp: A Review and Case Studies of Surgical Reconstruction
Why this particular demographic skew exists is not entirely clear. Curly or coiled hair follicles may be more prone to the type of blockage that kicks the disease off, but hormonal factors likely play a role too, given the strong male predominance and the typical onset around puberty or shortly after. The rarity of the condition in women and in other ethnic groups means that research cohorts tend to be small, and much of what clinicians know still comes from case series rather than large trials.
What Happens Inside the Scalp
The root problem is follicular occlusion. The upper portion of a hair follicle becomes plugged with excess keratin, the same tough protein that makes up hair and the outer layer of skin. Once blocked, the follicle swells, eventually ruptures beneath the surface, and spills its contents into the surrounding tissue. The immune system treats that material as a foreign invader and mounts a fierce inflammatory response, recruiting waves of white blood cells to the area.3Romanian Journal of Morphology and Embryology. The importance of histopathologic aspects in the diagnosis of dissecting cellulitis of the scalp
Over time, this cycle of plugging, rupturing, and inflammation leads to the formation of interconnecting sinus tracts, essentially tunnels that weave beneath the scalp and can drain pus at multiple points. A recent biopsy study found that even in clinically normal-appearing scalp adjacent to active lesions, every sample showed a consistent pattern of inflammation and scarring around the follicles. Active nodules added heavy neutrophil infiltration, granulation tissue, and complete loss of the sebaceous (oil) glands that normally sit alongside hair follicles.4PubMed Central. Perifollicular Lymphocytic Inflammation and Fibrosis in Dissecting Cellulitis: Evidence of a Consistent Histopathologic Pattern That finding matters because it suggests the disease is simmering even in skin that looks uninvolved, which helps explain why flare-ups keep returning.
Bacteria are frequently cultured from draining lesions, and secondary infection certainly worsens symptoms. But the initiating event is mechanical and immunological, not infectious. Antibiotics help partly because many of them also have anti-inflammatory properties, not just because they kill bacteria.
The Follicular Occlusion Tetrad
Dissecting cellulitis does not exist in isolation. It belongs to a group of four related conditions that share the same underlying follicular-occlusion mechanism: hidradenitis suppurativa (painful lumps typically in the groin and armpits), acne conglobata (severe, interconnected cystic acne), and pilonidal sinus (an abscess-prone cyst near the tailbone).5PubMed Central. Follicular occlusion tetrad A person with dissecting cellulitis may have one or more of these sibling conditions simultaneously, and recognizing the overlap can speed up diagnosis.
The relationship between dissecting cellulitis and hidradenitis suppurativa is especially close. Both involve follicular occlusion, follicle rupture, pus formation, tunnel development, and scarring. Some researchers have proposed that dissecting cellulitis is essentially hidradenitis suppurativa of the scalp, modified by the unique anatomy of that site, rather than a wholly separate disease.6PubMed. Dissecting Cellulitis and Hidradenitis Suppurativa: Two Diseases or One Follicular-Occlusion Spectrum? That view remains debated, and molecular-level proof is still lacking, but the clinical and histological similarities are hard to ignore.7PubMed. Are dissecting cellulitis and hidradenitis suppurativa different diseases? The practical upshot for patients is that drugs developed for hidradenitis suppurativa often work for dissecting cellulitis too.
What It Looks and Feels Like
Early dissecting cellulitis can be deceptive. It may start as a few tender bumps on the crown or back of the scalp that look a lot like ordinary folliculitis or even ingrown hairs. Over weeks to months, those bumps enlarge into firm, painful nodules. Some nodules soften and become fluctuant, meaning they feel like they contain fluid, and they may drain foul-smelling pus spontaneously or with pressure. As the disease progresses, sinus tracts form between nodules, creating a boggy, interconnected network under the skin. Pressing on one nodule may cause pus to emerge from a distant opening.
Hair loss develops in the affected areas and is typically permanent because the scarring process destroys the follicles themselves. This scarring alopecia can be disfiguring and carries a serious psychological burden. Patients commonly report pain, social embarrassment, and significant impacts on quality of life.8PubMed Central. Dissecting Cellulitis of the Scalp: A Case Report
How It Gets Diagnosed
Diagnosis is primarily clinical, meaning a dermatologist can often recognize it by looking at and feeling the scalp. The combination of fluctuant nodules, interconnecting sinus tracts, and scarring hair loss in a young man of African descent is highly suggestive. A skin biopsy can confirm the diagnosis and rule out mimics. The histopathology typically shows deep inflammation centered on ruptured follicles, with neutrophils dominating active lesions and fibrosis building up in chronic ones.
Ultrasound has emerged as a useful adjunct, particularly in early or atypical cases. Color Doppler imaging can reveal fluid collections in the deep skin layers connected to widened hair follicles, sometimes containing debris and hair fragments, even before the disease is clinically obvious.9PubMed Central. Dissecting Cellulitis of the Scalp Early Diagnosed by Color Doppler Ultrasound Ultrasound can also help distinguish dissecting cellulitis from other scalp conditions like trichilemmal cysts or folliculitis decalvans, and it allows clinicians to monitor how well treatment is controlling the underlying inflammation over time.10Journal of the Portuguese Society of Dermatology and Venereology. Use of Skin Ultrasound Imaging in Dissecting Cellulitis: Two Cases and Review
Conditions That Can Look Similar
Several other scalp diseases cause hair loss with inflammation and can be confused with dissecting cellulitis, especially early on. Folliculitis decalvans, for instance, produces pustules around hair follicles and progressive scarring alopecia, and distinguishing it from dissecting cellulitis requires careful attention to clinical pattern and biopsy findings.11PubMed Central. Folliculitis Decalvans: An Uncommon Case Report with Review of Literature Central centrifugal cicatricial alopecia and lichen planopilaris also enter the differential, particularly in darker-skinned patients. Infected scalp cysts, carbuncles, and even fungal infections (kerion) can sometimes mimic a single nodule of dissecting cellulitis. A biopsy and sometimes a fungal culture are the most reliable ways to sort these out.
Treatment With Antibiotics
Oral antibiotics have been the traditional first step. A systematic review pooling data from multiple studies found an overall response rate to systemic antibiotics of about 98 percent, but that number comes with important caveats.12PubMed Central. Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm “Response” in these studies often meant some improvement in symptoms, not a cure. In one prospective trial, seven patients treated with doxycycline improved after three months, but none achieved complete clearance. A larger retrospective cohort showed moderate improvement with various antibiotics, but patients frequently relapsed once the drugs were stopped.
The antibiotics used most often include doxycycline, clindamycin combined with rifampin, dapsone, and azithromycin. Their benefit is thought to come at least as much from anti-inflammatory effects as from antibacterial action. Time to response varied wildly across studies, from as little as six days to as long as 18 months, and the tendency to relapse after stopping treatment is a recurring theme. For many patients, antibiotics buy time and reduce symptoms but do not alter the underlying disease course.
Isotretinoin
Isotretinoin, the oral retinoid best known for treating severe acne, has shown strong results in dissecting cellulitis. A meta-analysis estimated an overall efficacy rate of about 90 percent, with a sensitivity analysis suggesting the true figure falls somewhere between 83 and 94 percent.13PubMed Central. Systematic Review Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis That is encouraging, but recurrence was seen in about a quarter of patients who initially responded, meaning the disease came back after the drug was stopped.
Isotretinoin works by shrinking oil glands, reducing the keratin buildup that plugs follicles, and dampening inflammation. It requires careful monitoring through blood tests because of potential effects on liver function and blood lipids, and it is a potent teratogen, meaning it causes severe birth defects and cannot be taken during pregnancy. For young men, who make up the bulk of dissecting cellulitis patients, the pregnancy risk is less of a direct concern, but the drug’s side effects, including dry skin, dry eyes, and occasional mood changes, still need to be managed.
Biologic and Targeted Therapies
The most significant shift in treatment has come from biologic drugs originally developed for conditions like psoriasis and hidradenitis suppurativa. Because dissecting cellulitis shares immunological pathways with those diseases, particularly involving tumor necrosis factor alpha, interleukin-17, and interleukin-23, the same drugs that block those inflammatory signals can calm the scalp disease too.14PubMed Central. Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
A systematic review of biologics and small-molecule inhibitors for dissecting cellulitis found that TNF-alpha blockers, the most frequently studied class, achieved overall response rates above 80 percent. Adalimumab and infliximab were the most commonly reported agents. Drugs targeting interleukin-17 and interleukin-23 showed encouraging results in patients whose disease had resisted earlier treatments, and JAK inhibitors have emerged as an additional option.15PubMed Central. Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review A separate systematic review echoed these findings, noting that TNF-alpha blockers and interleukin inhibitors were associated with clinical improvement in most individuals with moderate-to-severe disease, especially those who had failed earlier treatments.16PubMed Central. A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
These are not first-line agents yet. They are expensive, require injections or frequent lab monitoring, and carry risks of immune suppression. But for patients with moderate-to-severe disease who have cycled through antibiotics and isotretinoin without lasting relief, biologics represent a genuine step forward. One caveat: nearly all of the evidence comes from case reports and small case series rather than randomized controlled trials, so response rates should be interpreted cautiously.
When Surgery Becomes Necessary
In advanced cases where sinus tracts are extensive and the scalp is heavily scarred, medical therapy alone may not be enough. Surgical excision of the affected scalp tissue, sometimes down to the bone, removes the diseased follicles and interconnecting tunnels entirely. The resulting wound can be reconstructed with skin grafts or flaps. One reported approach involved wide excision of the scalp followed by reconstruction using a free muscle flap from the back covered with a meshed skin graft.17PubMed Central. Surgical management of dissecting cellulitis of the scalp using free latissimus dorsi flap and meshed split–thickness skin graft: A case report
Surgery is generally reserved for patients who have failed medical management or whose disease is so far advanced that medications cannot address the structural damage. Results have been mixed in the literature. Some small case series have reported complete recovery with no recurrence over several years of follow-up, while others found that surgery reduced pain but did not halt disease progression.18PubMed Central. Treatments for Dissecting Cellulitis of the Scalp: A Systematic Review and Treatment Algorithm – Section: Procedural Treatments / Surgical Interventions The difference may come down to how radical the excision is and whether any affected tissue is left behind. Less aggressive procedures like incision and drainage of individual abscesses provide temporary relief but do not address the underlying tunneling network.
Why Recurrence Is So Common
A frustrating hallmark of dissecting cellulitis is its tendency to come back. Antibiotics work while you take them and then the disease flares when you stop. Isotretinoin clears it in most patients, but about a quarter relapse.19PubMed Central. Systematic Review Analyzing the Efficacy of Isotretinoin in Treating Dissecting Cellulitis: A Literature Review and Meta-Analysis Even biologics, for all their promise, typically require ongoing use. The biopsy findings discussed earlier help explain why: inflammation and fibrosis are already present in clinically normal-appearing scalp, meaning the disease process is more widespread than what the eye can see. Stopping a drug removes the brake on that smoldering inflammation, and the cycle reignites.
This chronicity has real implications for how patients and doctors should think about treatment. Dissecting cellulitis is better managed as a chronic disease, controlled rather than cured, than as something that can be knocked out with a single course of medication. Early, aggressive treatment may limit the extent of scarring and hair loss, which is why timely diagnosis matters so much.
The Psychological and Social Toll
The visible nature of scalp disease, combined with painful flares and malodorous drainage, takes a heavy psychological toll. Permanent hair loss in young adults, the demographic most commonly affected, can be particularly distressing. The condition may result in scarring disfigurement and significantly impaired quality of life.20PubMed Central. Dissecting Cellulitis of the Scalp: A Case Report Social stigma is compounded by the fact that many people, including some healthcare providers, mistake the draining lesions for a contagious infection or a hygiene problem, neither of which is true.
Patients often describe frustration with the healthcare system itself. Because the condition is rare, primary care physicians may not recognize it, leading to repeated courses of standard antibiotics for presumed “scalp infections” before a referral to dermatology. Once diagnosed, the lack of standardized treatment guidelines means that management is often trial and error, with patients cycling through multiple therapies before finding something that controls their disease.
Emerging Directions and Unanswered Questions
Evidence-based guidelines for dissecting cellulitis still do not exist. Recent reviews have noted that while the therapeutic toolbox has expanded considerably, from antibiotics and retinoids to biologics, JAK inhibitors, laser therapies, and photodynamic protocols, the evidence base behind each option remains thin. Adjunctive approaches like laser hair removal, which aims to eliminate the follicles that serve as the disease’s starting point, have gained interest as a way to reduce flares in affected areas, though data are limited to small case series.
The reclassification debate is worth watching. If dissecting cellulitis and hidradenitis suppurativa are ultimately confirmed to be the same disease expressed at different body sites, clinical trials for hidradenitis suppurativa, which are far more numerous and better funded, could directly inform treatment of scalp disease. That would be a major practical benefit for patients, opening access to drugs and treatment algorithms that have already been validated in larger populations. For now, clinicians are borrowing from the hidradenitis suppurativa playbook based on shared pathology, but formal recognition of the overlap could accelerate drug approvals and insurance coverage for biologics used off-label in scalp disease.